Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
Saved in:
Main Authors: | Wulffraat NM (Author), Rademaker C (Author), Sinnema G (Author), Bulatović M (Author), Verkaaik M (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
by: Zhang L, et al.
Published: (2020) -
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
by: Jing Zhang, et al.
Published: (2020) -
Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients
by: Casper G. Schoemaker, et al.
Published: (2018) -
Effect of the antirheumatic medication methotrexate (MTX) on biomechanical compressed human periodontal ligament fibroblasts (hPDLFs)
by: Claudia Welte-Jzyk, et al.
Published: (2024) -
Relationship Between the Free and Total Methotrexate Plasma Concentration in Children and Application to Predict the Toxicity of HD-MTX
by: Wei-Chong Dong, et al.
Published: (2021)